Virtu Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-11,978
| Closed | -$191K | – | 1395 |
|
2024
Q1 | $191K | Buy |
+11,978
| New | +$191K | 0.01% | 802 |
|
2022
Q4 | – | Sell |
-88,892
| Closed | -$1.14M | – | 1700 |
|
2022
Q3 | $1.14M | Buy |
+88,892
| New | +$1.14M | 0.1% | 171 |
|
2021
Q3 | – | Sell |
-13,295
| Closed | -$76K | – | 1572 |
|
2021
Q2 | $76K | Buy |
+13,295
| New | +$76K | 0.01% | 1262 |
|
2020
Q4 | – | Sell |
-62,022
| Closed | -$184K | – | 1488 |
|
2020
Q3 | $184K | Buy |
+62,022
| New | +$184K | 0.03% | 604 |
|
2019
Q4 | $40K | Buy |
+10,725
| New | +$40K | ﹤0.01% | 1235 |
|
2019
Q2 | – | Sell |
-112,568
| Closed | -$574K | – | 1489 |
|
2019
Q1 | $574K | Buy |
112,568
+8,062
| +8% | +$41.1K | 0.03% | 489 |
|
2018
Q4 | $201K | Buy |
+104,506
| New | +$201K | 0.01% | 951 |
|
2018
Q1 | – | Sell |
-16,764
| Closed | -$66K | – | 2038 |
|
2017
Q4 | $66K | Sell |
16,764
-13,608
| -45% | -$53.6K | ﹤0.01% | 2017 |
|
2017
Q3 | $77K | Buy |
+30,372
| New | +$77K | ﹤0.01% | 2134 |
|